Immix Biopharma Inc
IMMX
Get informed when a big investor buys or sells
+ FollowMarket Cap$489.7M
Close$
$2.82
66.6% downside
Current Fair Value
66.6% downsideOvervalued by 66.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $489.70 Million |
|---|---|
| Enterprise Value | $411.49 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.89 |
| Beta | 0.12 |
| Outstanding Shares | 38,286,116 |
Return
| Return on Equity | -41.47% |
|---|---|
| Return on Assets | -36.51% |
| Return on Invested Capital | -42.08% |
Valuation & Multiples
| P/E Ratio | -9.85 |
|---|---|
| PEG | -8.07 |
| Price to Sales | - |
| Price to Book Ratio | 4.22 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.47 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 14, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.5154▲ 200.97% |
|---|---|
| Total Calls | 26,000▼ 26.14% |
| Total Puts | 91,400▲ 72.45% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 70.72%▼ 5.65% |
|---|---|
| Total Invested | $246.62M▲ 93.43% |
| Investors Holding | 79▲ 10.00% |
ESG Score
No data